drugset / Trial / NCT02211898

Clinical Study of BNS003 on Swelling in Legs Due to Venous Reflux

NCT02211898 ↗

Phase 3 Completed 180 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

To investigate the efficacy and safety of BNS003 on subjective symptoms such as sensation of heaviness/tiredness(dullness), tension, tingling, pain, fever or itching associated with swelling of calf and ankle due to disorder of leg venous reflux.

Timeline

Start
2004-07
Primary completion
2005-01
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject BNS003 Unknown — —

Indications